Filing Details
- Accession Number:
- 0000059478-18-000192
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-07-27 13:58:22
- Reporting Period:
- 2018-07-26
- Accepted Time:
- 2018-07-27 13:58:22
- Original Submission Date:
- 2018-07-27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
59478 | Lilly Eli & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1173275 | P Jackson Tai | Lilly Corporate Center Indianapolis IN 46285 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-07-26 | 2,168 | $95.22 | 53,228 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This amendment is being filed to correctly report the footnote of the original Form 4 which was intended to be placed in column 4 Price.
- This transaction was executed in multiple trades at prices ranging from $95.00 to $95.40. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.